¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2021 Ãá°èÇмú´ëȸ : 2021-04-10

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2021 Ãá°èÇмú´ëȸ : 2021-04-10
±³À°ÀÏÀÚ : 2021-04-10
±³À°Àå¼Ò : ÀÓÇǸ®¾óÆÓ¸®½º È£ÅÚ ¼­¿ï  
±³À°ÁÖÁ¦ : ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2021 Ãá°èÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇÑÆÄŲ½¼º´¹×ÀÌ»ó¿îµ¿ÁúȯÇÐȸ
´ã´çÀÚ : ±è½Ã¿ø
¿¬¶ôó : 02-6395-2876  
À̸ÞÀÏ : movement@kmds.or.kr      
±³À°Á¾·ù : ½Å°æ°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í Á¤È¸¿ø 30,000¿ø / ÁØȸ¿ø 20,000¿ø / ºñȸ¿ø 40,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 09:00~09:40 alpha-synuclein pathology in the skin  Charles Adler(Mayo Clinic, USA) 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 09:40~10:10 Neuromodulation in PD and neurodegnerative diseases  ¿ÀÀÀ¼®(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 10:10~10:40 Recent clinical trials in PD: positive and negative  Ãµ»ó¸í(µ¿¾ÆÀÇ´ë) 
È޽Ġ04-10  10:40~10:50 È޽Ġ () 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 10:50~11:20 The link between two pathogenic mechanisms: synucleinopathy and inflammation in PD  ±è¿µÀº(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 11:20~11:50 GBA, lysosome and PD  Ç㿵Àº(Â÷ÀÇ°úÇдë) 
È޽Ġ04-10  11:50~12:00 È޽Ġ () 
±âŸ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 12:00~13:00 ÃÑȸ ¹× Á¡½É½Ä»ç  ±Çµµ¿µ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 13:00~13:30 Autonomic dysfunction in PD: pathophysiology and management  ¿ÀÀ±»ó(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 13:30~14:00 Update in medical treatment for PD  ÀÌÁöÀº(±¹¹Î°Ç°­º¸Çè°ø´ÜÀϻ꺴¿ø) 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 14:00~14:30 Iron-sensitive MRI in parkinsonism  ÀÌÀçÇõ(ºÎ»êÀÇ´ë) 
È޽Ġ04-10  14:30~14:40 È޽Ġ () 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 14:40~15:10 iRBD and syncleinopathy  ÀÌÁö¿µ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 15:10~15:40 Rare genetic disorders with parkinsonism  Àå¿ì¿µ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 15:40~16:20 Heterogeneity of PD  Robert de Bie(Amsterdam UMC) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2021 Ãá°èÇмú´ëȸ : 2021-04-10""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ Æó·ÅÈ£Èí±â¿¬±¸È¸-Áúº´°ü¸®Ã» ÈÄ¿ø½ÉÆ÷Áö¿ò : 2021-04-10
´ÙÀ½±Û Á¶¼±´ëÇб³º´¿ø 2021 ´ëÇѼºÇü¿Ü°úÇÐȸ ±¤ÁÖÀü³²Áöȸ Ãß°èÇÐȸ : 2021-04-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 3 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 4 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 2 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 5 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 2 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 2 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 1 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 0 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 0 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 0 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 2 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 0 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 1 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 0 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 4 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷